These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24839800)

  • 1. Radium-223 vs EBRT for multiple painful bone metastases: the data favor radium-223.
    Vogelzang NJ
    Oncology (Williston Park); 2014 Apr; 28(4):296, 298. PubMed ID: 24839800
    [No Abstract]   [Full Text] [Related]  

  • 2. Radium-223 vs EBRT for multiple painful bone metastases: is less more?
    Roach M
    Oncology (Williston Park); 2014 Apr; 28(4):297-8. PubMed ID: 24839801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts].
    Bertolaso P; Leroy L; Gross-Goupil M; Aupee O; Ravaud A; Roubaud G; Cazeau AL; Le Moulec S
    Bull Cancer; 2017 Sep; 104(9):762-770. PubMed ID: 28797482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection.
    Cheetham PJ; Petrylak DP
    Oncology (Williston Park); 2012 Apr; 26(4):330-7, 341. PubMed ID: 22655525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative radiotherapy for prostate cancer.
    Boyer MJ; Salama JK; Lee WR
    Oncology (Williston Park); 2014 Apr; 28(4):306-12. PubMed ID: 24839802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.
    Wale DJ; Viglianti BL; Gross MD; Ferretti A; Rubello D; Wong KK
    Am J Clin Oncol; 2019 Jan; 42(1):99-106. PubMed ID: 30204613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized trial: a comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic castrate resistance prostate cancer (mCRPC) patients with painful bone metastases.
    Baczyk M; Milecki P; Pisarek M; Gut P; Antczak A; Hrab M
    Neoplasma; 2013; 60(3):328-33. PubMed ID: 23374004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radium-223 for men with hormone-refractory prostate cancer and bone metastases.
    Shelley MD; Mason MD
    Lancet Oncol; 2007 Jul; 8(7):564-5. PubMed ID: 17613416
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone-targeting radiopharmaceuticals including radium-223.
    Brady D; Parker CC; O'Sullivan JM
    Cancer J; 2013; 19(1):71-8. PubMed ID: 23337760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer.
    Nilsson S; Strang P; Aksnes AK; Franzèn L; Olivier P; Pecking A; Staffurth J; Vasanthan S; Andersson C; Bruland ØS
    Eur J Cancer; 2012 Mar; 48(5):678-86. PubMed ID: 22341993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
    Bruland ØS; Nilsson S; Fisher DR; Larsen RH
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of palliative external beam radiation therapy in boney metastases pain management.
    Cai B; Nickman NA; Gaffney DK
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):28-34. PubMed ID: 23394451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation for bone metastases.
    Bourgeois DJ; Kraus S; Maaloof BN; Sartor O
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):227-32. PubMed ID: 21734581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
    Rubini G; Nicoletti A; Rubini D; Asabella AN
    Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative treatment of bone metastases with bone-seeking radionuclides].
    De Klerk JM; Zonnenberg BA; Huiskes AW; Han SH; Blijham GH; Van Rijk PP
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2618-22. PubMed ID: 10028362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone metastases treated with radiopharmaceuticals].
    Giammarile F
    Bull Cancer; 2013 Nov; 100(11):1223-7. PubMed ID: 24409472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-centre Experience of Use of Radium 223 with Clinical Outcomes Based on Number of Cycles and Bone Marrow Toxicity.
    Dadhania S; Alonzi R; Douglas S; Gogbashian A; Hughes R; Dalili D; Vasdev N; Adshead J; Lane T; Westbury C; Anyamene N; Ostler P; Hoskin P; Sharma A
    Anticancer Res; 2018 Sep; 38(9):5423-5427. PubMed ID: 30194198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radium-223 Therapy of Bone Metastases in Prostate Cancer.
    Nilsson S
    Semin Nucl Med; 2016 Nov; 46(6):544-556. PubMed ID: 27825434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radium-223 dichloride for the treatment of metastatic prostate cancer.
    Turner PG; O'Sullivan J
    Expert Opin Pharmacother; 2014 Oct; 15(14):2105-11. PubMed ID: 25186336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-based approaches for therapy and palliation of advanced prostate cancer.
    Lewis B; Sartor O
    Curr Opin Urol; 2012 May; 22(3):183-9. PubMed ID: 22453334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.